Aster CMI Hospital Strengthens Neurosciences Care with Next-Generation Surgical Robotics

IMT News Desk
IMT News Desk
· 2 min read
Aster CMI Hospital adds Mazor X and ROSA robotic systems to boost precision in spine and brain surgeries, advancing neurosciences care in India.

Aster CMI Hospital has introduced two state-of-the-art robotic platforms for neurosurgery: Mazor X for spine surgery and ROSA for cranial and brain procedures.

The robotic platforms were inaugurated by Mr. Venkatesh Prasad, President of the Karnataka State Cricket Association (KSCA), in the presence of senior leadership and clinical experts from Aster CMI Hospital, Bangalore.

A breakthrough introduced through the ROSA robotic platform is frameless brain surgery technology, transforming the way neurosurgical procedures are performed in India. With ROSA’s frameless robotic technology, surgeons can now achieve sub-millimetric precision without the discomfort and invasiveness associated with conventional frame-based systems. The ROSA system supports complex brain tumor surgeries, epilepsy procedures, stereotactic neurosurgery, and movement disorder interventions while helping preserve critical brain functions.

The Mazor X robotic guidance system is designed for spine surgeries and assists surgeons with highly precise planning and placement of spinal implants. The technology enhances surgical accuracy, minimizes human error, reduces radiation exposure, and supports minimally invasive approaches that can lead to smaller incisions, reduced blood loss, shorter hospital stays, and quicker rehabilitation for patients.

Dr. Ravi Gopal Varma, Director – Aster Global Centre of Excellence in Neurosciences & Lead Consultant – Neurosurgery, Aster CMI Hospital said, “The introduction of Mazor X and ROSA robotics represents a major milestone in advancing neurosciences care in India. The frameless capabilities of ROSA are transforming the way brain surgeries are performed by improving precision while making procedures significantly less invasive and more comfortable for patients. These technologies allow us to achieve exceptional surgical accuracy in highly complex brain and spine procedures.”

Dr. Akshay Hari, Consultant – Neurosurgery and Spine Surgery, Aster CMI Hospital, added, “Robotic-assisted spine surgery with Mazor X enables detailed pre-operative planning and extremely accurate implant positioning, which is critical in complex spine surgeries. With enhanced precision and reduced tissue damage, patients can experience faster recovery, reduced pain, and improved long-term results.”

Commenting on the development, Dr. Prashanth N, CEO, Aster Hospitals, Karnataka, said, “At Aster, we continuously invest in advanced technologies that redefine patient care. The addition of Mazor X and ROSA robotic systems further strengthens our Neurosciences program and reinforces our commitment to bringing world-class, technology-driven healthcare solutions to patients across India and beyond.”

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk